⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14887250 | 0.71 | — | — | |
| SCHEMBL4273507 | 0.71 | — | — | |
| SCHEMBL219313 | 0.54 | — | — | |
| SCHEMBL3166412 | 0.48 | — | — | |
| SCHEMBL4584646 | 0.45 | — | — | |
| SCHEMBL4584754 | 0.44 | — | — | |
| SCHEMBL3265453 | 0.40 | — | — | |
| SCHEMBL27893114 | 0.38 | — | — | |
| SCHEMBL27667849 | 0.34 | — | — | |
| SCHEMBL2965731 | 0.31 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2726468-B1 | SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF | ALECTOS THERAPEUTICS INC (CA) | 2017-04-12 | — | — | EP | claimed |
| EP-2569291-B1 | SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF | UNIV FRASER SIMON (CA) | 2016-04-06 | — | — | EP | claimed |
| EP-2744338-A1 | SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF | Merck Sharp & Dohme Corp. (US) | 2014-06-25 | — | — | EP | claimed |
| EP-2726468-A1 | SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF | Alectos Therapeutics Inc. (CA) | 2014-05-07 | — | — | EP | claimed |
| EP-2569291-A1 | SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF | Simon Fraser University (CA) | 2013-03-20 | — | — | EP | claimed |
| WO-2013025452-A1 | SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF | MERCK SHARP & DOHME CORP. (US) | 2013-02-21 | — | — | WO | claimed |
| WO-2013000085-A1 | SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF | ALECTOS THERAPEUTICS INC. (CA) | 2013-01-03 | — | — | WO | claimed |
| WO-2011140640-A1 | SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF | SIMON FRASER UNIVERSITY (CA) | 2011-11-17 | — | — | WO | claimed |
| CN-114555573-A | Prostaglandin E2(PGE2)EP4Receptor antagonists | 多曼治疗学公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-108368143-A | Monomaleimide functionalized platinum compounds for cancer therapy | 维也纳医科大学 | 2018-08-03 | — | — | CN | disclosed |
| CN-104995183-B | Novel phosphodiesterase type 10A inhibitor compounds | 艾伯维公司 | 2018-04-06 | — | — | CN | disclosed |
| CN-104703980-B | Belong to the orexin receptor antagonists of [adjacent double (miscellaneous) aryl] [base of 2 (double (miscellaneous) aryl) pyrrolidines 1] ketone derivatives | 埃科特莱茵药品有限公司 | 2017-09-22 | — | — | CN | disclosed |
| EP-2726468-B1 | SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF | ALECTOS THERAPEUTICS INC (CA) | 2017-04-12 | — | — | EP | disclosed |
| EP-2726468-A1 | SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF | Alectos Therapeutics Inc. (CA) | 2014-05-07 | — | — | EP | disclosed |
| EP-2569291-A1 | SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF | Simon Fraser University (CA) | 2013-03-20 | — | — | EP | disclosed |
| WO-2013000085-A1 | SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF | ALECTOS THERAPEUTICS INC. (CA) | 2013-01-03 | — | — | WO | disclosed |
| WO-2011140640-A1 | SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF | SIMON FRASER UNIVERSITY (CA) | 2011-11-17 | — | — | WO | disclosed |
| US-6579846-B1 | Thickeners for cosmetics | BASF AKTIENGESELLSCHAFT (DE) | 2003-06-17 | — | — | US | disclosed |